Measuring the improvement in overall survival among patients with advanced gastroenteropancreatic neuroendocrine tumors over the past two decades

Key Points

• This research aims to evaluate changes in survival rates of patients with advanced gastroenteropancreatic neuroendocrine tumors over time.
• Conducted multivariable analysis of survival outcomes
• Compared patients diagnosed in two periods: 2004-2013 and 2014-2022
• Assessed well-differentiated gastroenteropancreatic neuroendocrine tumors
• Patients diagnosed from 2014 to 2022 exhibited better survival outcomes than those diagnosed from 2004 to 2013
• The analysis indicates a significant improvement in overall survival rates over the evaluated periods